SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-003481
Filing Date
2019-05-09
Accepted
2019-05-09 16:17:59
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_033119.htm 10-Q 891836
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 10233
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 10089
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4437
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4927
  Complete submission text file 0001387131-19-003481.txt   3943303

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT admp-20190331.xml EX-101.INS 731244
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20190331.xsd EX-101.SCH 35467
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20190331_cal.xml EX-101.CAL 62192
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20190331_def.xml EX-101.DEF 146209
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20190331_lab.xml EX-101.LAB 302520
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20190331_pre.xml EX-101.PRE 235388
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 19810799
SIC: 2834 Pharmaceutical Preparations